A treatment to reverse the symptoms of Alzheimer's is moving to human trials
An aging population means Alzheimer's is becoming increasingly common. Image: REUTERS/Nacho Doce
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Neuroscience
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on NeuroscienceSee all
Bryan Stallings
February 13, 2023
Michael Platt and Elizabeth (Zab) Johnson
January 30, 2023
Mark Michaud
January 26, 2023
Marcus Richards and Jonathan M Schott
November 24, 2022
James Devitt
November 3, 2022
Tim Palmer
October 24, 2022